Floatz logo

377 assets in Pancreatic Neoplasm

Therapeutic assets addressing Pancreatic Neoplasm, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
Erfonrilimab
Pancreatic Neoplasm
InxMed (Shanghai) Co., Ltd.P1/2CC (40)
Fmc-376
Pancreatic Neoplasm
Frontier Medicines CorporationP1/2CC (40)
gi-108
Pancreatic Neoplasm
GI Innovation, Inc.P1/2CC (40)
Ifebemtinib
Pancreatic Neoplasm
InxMed (Shanghai) Co., Ltd.P1/2CC (40)
il-15 enhanced engineered nk cells
Pancreatic Neoplasm
M.D. Anderson Cancer CenterP1/2CC (40)
jmt203
Pancreatic Neoplasm
Shanghai JMT-Bio Inc.P1/2CC (40)
js007
Pancreatic Neoplasm
Fudan UniversityP1/2CC (40)
js015
Pancreatic Neoplasm
Fudan UniversityP1/2CC (40)
Kras Neoantigen Nanovaccine
Pancreatic Neoplasm
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical SchoolP1/2CC (40)
mdx2001
Pancreatic Neoplasm
ModeX Therapeutics, An OPKO Health CompanyP1/2CC (40)
Mkrasvax
Pancreatic Neoplasm
Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsP1/2CC (40)
Mutant Kras G12V-Specific Tcr Transduced Autologous T Cells
Pancreatic Neoplasm
Changhai HospitalP1/2CC (40)
Narmafotinib
Pancreatic Neoplasm
Amplia Therapeutics LimitedP1/2CC (40)
Neoantigen Specific Tcr-T Cell Drug Product
Pancreatic Neoplasm
Alaunos TherapeuticsP1/2CC (40)
Nuv-1511
Pancreatic Neoplasm
Nuvation Bio Inc.P1/2CC (40)
Odm-212
Pancreatic Neoplasm
Orion Corporation, Orion PharmaP1/2CC (40)
Osemitamab
Pancreatic Neoplasm
Suzhou Transcenta Therapeutics Co., Ltd.P1/2CC (40)
pbp1510
Pancreatic Neoplasm
Prestige Biopharma LimitedP1/2CC (40)
Pertzye
Pancreatic Neoplasm
Memorial Sloan Kettering Cancer CenterP1/2CC (40)
Polo-Like Kinase 1 Inhibitor Nms-1286937
Pancreatic Neoplasm
University of Kansas Medical CenterP1/2CC (40)
Precemtabart Tocentecan
Pancreatic Neoplasm
EMD Serono Research & Development Institute, Inc.P1/2CC (40)
Pucotenlimab
Pancreatic Neoplasm
Zhejiang Provincial People's HospitalP1/2CC (40)
rp-001
Pancreatic Neoplasm
Recurv Pharma IncP1/2CC (40)
Saruparib
Pancreatic Neoplasm
AstraZenecaP1/2CC (40)
Satricabtagene Autoleucel
Pancreatic Neoplasm
CARsgen Therapeutics Co., Ltd.P1/2CC (40)
Shr-8068
Pancreatic Neoplasm
Fudan UniversityP1/2CC (40)
Solnerstotug
Pancreatic Neoplasm
Sensei Biotherapeutics, Inc.P1/2CC (40)
sot102
Pancreatic Neoplasm
SOTIO Biotech a.s.P1/2CC (40)
Sotorasib
Pancreatic Neoplasm
Orion Corporation, Orion PharmaP1/2CC (40)
Tak-500
Pancreatic Neoplasm
TakedaP1/2CC (40)
tc-510
Pancreatic Neoplasm
TCR2 TherapeuticsP1/2CC (40)
T-Dxd
Pancreatic Neoplasm
AstraZenecaP1/2CC (40)
Tgfbr2 Ko Car27/Il-15 Nk Cells
Pancreatic Neoplasm
M.D. Anderson Cancer CenterP1/2CC (40)
Tifcemalimab
Pancreatic Neoplasm
Fudan UniversityP1/2CC (40)
Trop2-Car-Nk
Pancreatic Neoplasm
M.D. Anderson Cancer CenterP1/2CC (40)
tt-4
Pancreatic Neoplasm
Tarus Therapeutics, Inc.P1/2CC (40)
vb15010
Pancreatic Neoplasm
Zhejiang Yangli Pharmaceutical Technology Co., Ltd.P1/2CC (40)
Vilamakitug
Pancreatic Neoplasm
XBiotech, Inc.P1/2CC (40)
Vodudeutentan Sodium
Pancreatic Neoplasm
ENB Therapeutics, IncP1/2CC (40)
vrt106
Pancreatic Neoplasm
Guangdong Provincial People's HospitalP1/2CC (40)
Zimberelimab
Pancreatic Neoplasm
James Cleary, MD, PhDP1/2CC (40)
177lu-dota-sna040
Pancreatic Neoplasm
SmartNuclide BiopharmaEarly P1C (39)
[68ga]ga-nodaga-sna014
Pancreatic Neoplasm
SmartNuclide BiopharmaEarly P1C (39)
bi 765049
Pancreatic Neoplasm
Boehringer IngelheimP1C (39)
Cabotamig
Pancreatic Neoplasm
Arbele Pty LtdP1C (39)
Cdx-585
Pancreatic Neoplasm
Celldex TherapeuticsP1C (39)
Cue-102
Pancreatic Neoplasm
Cue BiopharmaP1C (39)
Ezabenlimab
Pancreatic Neoplasm
Boehringer IngelheimP1C (39)
nmk89
Pancreatic Neoplasm
Nihon Medi-Physics Co., Ltd.P1C (39)
Optimized Neoantigen Synthetic Long Peptide Vaccine
Pancreatic Neoplasm
Washington University School of MedicineP1C (39)
Showing 201 to 250 of 377 assets
PreviousPage 5 of 8Next